10 participants
GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-16
- Start Date:
- 2023-09-18
- Completion:
- 2024-11-26
Conditions
- Biliary Tract Cancer
Interventions
- DRUG
No Results Yet